Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Express Scripts
Dow
Medtronic
Baxter

Last Updated: September 28, 2022

Investigational Drug Information for Seclidemstat


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Seclidemstat?

Seclidemstat is an investigational drug.

There have been 5 clinical trials for Seclidemstat. The most recent clinical trial was a Phase 1 trial, which was initiated on January 15th 2022.

The most common disease conditions in clinical trials are Liposarcoma, Histiocytoma, Benign Fibrous, and Sarcoma, Ewing. The leading clinical trial sponsors are Salarius Pharmaceuticals, LLC, HonorHealth Research Institute, and M.D. Anderson Cancer Center.

Recent Clinical Trials for Seclidemstat
TitleSponsorPhase
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Salarius Pharmaceuticals, LLCPhase 1/Phase 2
Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic CancersMerck Sharp & Dohme Corp.Phase 1
Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic CancersSalarius Pharmaceuticals, LLCPhase 1

See all Seclidemstat clinical trials

Clinical Trial Summary for Seclidemstat

Top disease conditions for Seclidemstat
Top clinical trial sponsors for Seclidemstat

See all Seclidemstat clinical trials

International Patents for Seclidemstat

Drugname Country Document Number Estimated Expiration Related US Patent
Seclidemstat Australia AU2012296639 2031-08-15 See Plans and Pricing
Seclidemstat Australia AU2014281398 2031-08-15 See Plans and Pricing
Seclidemstat Brazil BR112014003382 2031-08-15 See Plans and Pricing
Seclidemstat Brazil BR112015032113 2031-08-15 See Plans and Pricing
Seclidemstat Canada CA2843609 2031-08-15 See Plans and Pricing
Seclidemstat Canada CA2915817 2031-08-15 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Express Scripts
Dow
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.